$90.22
+0.80 (+0.89%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+122.55%
1Y
+325.57%
YTD
+187.32%
Open$89.94
Previous Close$89.42
Day High$91.30
Day Low$88.22
52W High$91.57
52W Low$19.02
Volume—
Avg Volume1.18M
Market Cap8.02B
P/E Ratio359.70
EPS$0.16
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.31
Above
SMA 200
$25.48
Above
RSI (14)
31.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
-52.2% upside
Current
$90.22
$90.22
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 163.60M | 12.24M | 783.80M |
| Net Income | -71,222,516 | -102,665,771 | 150.56M |
| Profit Margin | -43.5% | -885.1% | 19.2% |
| EBITDA | -53,063,398 | -104,281,125 | 266.89M |
| Free Cash Flow | — | — | 76.52M |
| Rev Growth | +115.0% | +2.9% | +0.6% |
| Debt/Equity | 1.49 | 1.49 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |